Portfolio
UCeed is making investments in early-stage UCalgary and community-based startup companies to advance problem-solving research, create jobs and fuel the economy.
Innovate Calgary in partnership with the Investment Advisory Groups, make UCeed investment decisions following a robust vetting process and thorough third-party validation. UCeed uses a milestone investment model to focus investees on key technical or business models that will help them engage with the private sector.
In addition to capital, UCeed provides commercialization expertise, mentorship and networking, and education and programming to make companies investor-ready. In order to build a sustainable innovation ecosystem, UCeed re-invests any returns back into the fund of origin to create an “evergreen” funding model.
Portfolio of Investments
Haskayne Student Fund
Cadence
Cadence is helping families, funeral homes and estate professionals navigate the complex process of estate settlement through their online platform.
Cohesic Solutions
Cohesic Solutions provides decision intelligence to physicians and healthcare executives that harnesses cutting-edge data science to inform care, reduce uncertainty, improve communication, increase efficiency, and accelerate research.
Innovere
Innovere Medical has developed the world’s first wireless TV that operates inside an MRI scanner. With this innovation, Innovere hopes to improve patient comfort during MRI exams, which cause anxiety in one out of three patients.
Child Health Fund
AazeinTx
AazeinTx is commercializing a novel, fast-acting, orally delivered compound for the treatment of acute and chronic asthma.
Fluid Biomed
Fluid Biomed is revolutionizing the approach to vascular disease by creating the first bioabsorbable brain stent to treat aneurysms.
Nimble Science
Nimble Science is developing an ingestible medical device capsule that samples small intestine contents for microbiome diagnostic applications obviating the need for invasive endoscopy procedures.
Trexo Robotics
Trexo Robotics has developed a sophisticated wearable robotic device (Trexo) to provide physiotherapy for children with walking impairments. The device monitors a child’s ability to move his/her legs with artificial intelligence algorithms and provides a level of assistance that maximizes therapeutic benefit.
Zymedyne
Zymedyne is developing therapeutics for the treatment of chronic pain that targets a recently discovered biological process that is abnormally activated in chronic pain conditions, offering an alternative to opioids.
Health Fund
Circle Neurovascular Imaging
Circle Neurovascular Imaging is on a mission to improve the outcomes of stroke patients through its clinically validated StrokeSENSTM technology. Using AI-assisted advanced technology, it can identify the right treatments for patients more quickly than traditional methods.
Deep Surface AI
Deep Surface AI is developing cosmetic surgery software that uses artificial intelligence and high-resolution models of human facial shape variation to provide fast and accurate cosmetic surgery planning.
Fluid Biomed
Fluid Biomed is developing a bioabsorbable flow diversion stent to treat brain aneurysms that offer improved safety and post-surgical brain imaging over conventional metallic stents.
freddie
PurposeMed has developed a digital platform, Freddie, to provide quick, discrete, and expert telemedicine services to prescribe and deliver HIV pre-exposure prophylaxis (PrEP) drugs to vulnerable populations, reducing the incidence of HIV infection and healthcare costs.
HelpWear
HelpWear is developing a non-invasive, wearable, heart monitoring system to record and diagnose heart rhythm disorders that offers substantial ease-of-use and longer patient recording time over conventional medical devices.
ILLUCIDx
Illucidx is developing an ultra-sensitive point-of-care diagnostic device that utilizes multiple disposable cartridges each containing assay chemistry for a different infectious disease.
Nimble Science
Nimble Science is developing an ingestible medical device capsule that samples small intestine contents for microbiome diagnostic applications obviating the need for invasive endoscopy procedures.
PulseMedica
Pulse Medica is developing a medical device to treat retinal eye diseases that affect over 400 million people worldwide. Their state-of-the-art technology will improve patient outcomes and quality of life.
Qualisure Diagnostics
Qualisure is developing a precision diagnostic test to guide the treatment of thyroid cancer, improving patient outcomes by reducing unnecessary surgical procedures and chemotherapy treatments and saving healthcare costs.
Reach Orthopaedics
Reach Orthopaedics is developing a shoulder implant to treat patients suffering from massive irreparable rotator cuff tears. Their design can increase mobility and function while eliminating chronic pain.
Syantra DX
Syantra Diagnostics is developing a blood-based diagnostic test to detect breast cancer.
Tactile Orthopaedics
Tactile Orthopaedics manufactures anatomically accurate human joint models that incorporate artificial bone, cartilage, and tendon components that have material properties that mimic that of living human tissue for arthroscopic surgical training, providing a cost-effective alternative to human cadaveric samples.
Zymedyne
Zymedyne is developing therapeutics for the treatment of chronic pain that targets a recently discovered biological process that is abnormally activated in chronic pain conditions, offering an alternative to opioids.
Social Impact Fund
Chroma Property Technologies
Chroma is Canada's first and only renter-focused lending platform, providing renters with simple products that make renting more affordable, convenient, flexible and rewarding. Chroma's mission is to accelerate social mobility and close the wealth gap between renters and homeowners.
Stagehand
Stagehand is reimagining live performances through an integrated web-based platform that allows businesses and other nontraditional venues and artists to work together to create meaningful experiences for the community.
Investment Advisors
Each UCeed fund is supported by an Investment Advisors who review and advise on Fund investments. These advisors are experienced professionals with deep sector experience, proven leadership, and knowledge and experience in early-stage investing. Advisors provide mentorship, deep-rooted community connections, and critical support through the investment decision-making process.
Our Funds
Haskayne Student Fund
Child Health Fund
Health Fund
